Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lilly describes several further series of estrogen receptor modulators

July 17, 1998

Genzyme General and Pharming to collaborate on Pompe's disease treatment

July 17, 1998

Genetronics develops TDD method for treating ED, seeks partners to carry on

July 16, 1998

Amylin completes enrollment in U.S. for phase III pramlintide studies

July 16, 1998

Vasomax NDA submitted for FDA review

July 16, 1998

Lilly describes serotonergic agents for treating obesity, CNS disorders

July 15, 1998

INVICORP approved for launch in Denmark

July 15, 1998

Vivus seeks partner to promote Muse in the U.S.

July 14, 1998

EM-800, a more potent antiestrogen than raloxifene in preclinical studies

July 14, 1998

New evidence supports the efficacy of PKC inhibition in diabetic neuropathy

July 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...